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Abstract 
Background: To identify the microorganisms that can grow rapidly in total parenteral nu-
trition (TPN) solutions, we investigated the growth of the major causes of catheter-related 
blood stream infection (Staphylococcus aureus, Serratia marcescens, Bacillus cereus, and Candida 
albicans) in TPN solutions containing lipid. Methods: The pH value of a TPN solution con-
taining lipid (pH 6.0, containing 20 ppm of NaHSO3) was adjusted by the addition of HCl to 
5.7, 5.4, or 4.9. The pH value of another TPN solution (pH5.5, containing 400 ppm of 
NaHSO3) was adjusted by the addition of NaOH to 5.9, 6.3, or 6.8. A specific number of each 
microorganism was added to 10 mL of each test solution and incubated at room temperature. 
The number of microorganisms was counted as colony forming units at 0, 24, and 48 hrs later. 
Results: C albicans increased similarly at any pH values in the TPN solution. The bacterial 
species also increased rapidly at pH6.0 in the solution containing 20 ppm of NaHSO3, but 
growth was suppressed as the pH value was reduced, with growth halted at pH4.9. However, 
these bacterial species did not increase, even at pH5.9, in the other solution containing 400 
ppm of NaHSO3. Conclusions: These results suggest that Candida species can grow rapidly in 
almost all TPN solutions regardless of the acidity, lipid, and NaHSO3; also, some bacterial 
species may grow in TPN solutions containing lipid unless the pH value is 5.0 or less. 
Therefore, each TPN solution should be examined whether or not the bacterial species can 
proliferate. 
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INTRODUCTION 
Catheter-related blood stream infection (CRBSI) 
is one of the most common complications of intra-
venous catheters.1-3 To reduce or prevent CRBSI, fac-
tors that enhance or inhibit microbial growth in pa-
renteral solutions should be investigated and identi-
fied. Total parenteral nutrition (TPN) solutions are 
considered to be relatively good growth media for 
microorganisms,1,4 whereas a number of investigators 
have shown that TPN solutions are poor growth me-
dia for most microorganisms that cause CRBSI, with 
the exception of Candida species.5-9 Likewise, we have 
previously confirmed that while bacterial species do 
not grow in TPN solutions without lipid, Candida 
species grow rapidly.10 Our data have shown that 
bacterial species cannot grow due to the acidity, but 
Candida species can grow regardless of the acidity.10 In 
contrast, most microorganisms grow rapidly in com-
mercial lipid emulsions,11-15 and sporadic CRBSI and Int. J. Med. Sci. 2010, 7 
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outbreaks have been traced to contaminated lipid 
emulsion.16,17 Because lipid emulsions have been 
shown to contribute to the rapid growth of most mi-
croorganisms that cause CRBSI, it can be assumed that 
TPN solutions containing lipid promote the microbial 
growth compared with TPN solutions without lipid.18 
Consequently, the Center for Disease Control and 
Prevention (CDC) has recommended that when any 
infusion solutions containing lipid are administered, 
the entire delivery system such as the administration 
set be replaced every 24 hours.19  
As the major causes of CRBSI, Staphylococcus 
aureus, Staphylococcus epidermidis, Serratia mar-
cescens, Escherichia coli, Klebsiella pneumonia, Can-
dida albicans, etc. were shown.2,3,6,11 Furthermore, 
blood stream infection outbreaks of Bacillus cereus via 
intravenous line were recently reported in Japan.20 In 
the present study, we investigated the growth in TPN 
solutions containing lipid of the same microorganisms 
studied previously:10 ie, Staphylococcus aureus as a 
delegate of gram positive cocci, Serratia marcescens as 
a delegate of gram negative rods, Bacillus cereus as a 
delegate of gram positive rods, and Candida albicans 
as a delegate of fungi. To clarify whether the acidity of 
TPN solutions suppresses microbial growth in the 
presence of lipid, the growth of all strains employed 
were investigated at various pH values in a commer-
cial TPN solution containing lipid in the first experi-
ment. To identify which factors enhance or inhibit the 
growth of each microorganism, we supplemented a 
TPN solution containing lipid with multivitamins, 
supplemented a TPN solution that did not contain 
lipid with lipid, and increased the bisulfite concentra-
tion in a TPN solution containing both lipid and mul-
tivitamins in the following experiments. 
MATERIALS AND METHODS 
Microorganisms employed 
A standard American Type Culture Collection 
(ATCC) strain and 1 clinical isolate were used for each 
microorganism; the standard strain ATCC6538 and 
the clinical isolate N3 of Staphylococcus aureus, the 
standard strain ATCC13880 and the clinical isolate N4 
of Serratia marcescens, the standard strain ATCC11778 
and the clinical isolate H2 of Bacillus cereus, and the 
standard strain ATCC10231 and the clinical isolate N7 
of Candida albicans. 
Test solutions 
A commercial TPN solution containing lipid 
(ML; MIXID-L, Otsuka Pharmaceutical Factory, Inc., 
Japan), a commercial TPN solution without lipid 
(AT1; AMINOTORIPA-1, Otsuka Pharmaceutical 
Factory, Inc.), multivitamins (MV; Otsuka MV Injec-
tion, Otsuka Pharmaceutical Factory, Inc.), a 20% lipid 
emulsion (IL; Intralipos 20%, Otsuka Pharmaceutical 
Factory, Inc.), and a physiological saline were used.   
The compositions of ML and AT1 are shown in Table 
1. 
 
Table 1. The compositions of ML and AT1 
Solution ML  AT1 
(volume) 900  mL  850 mL 
Amino acids  30.0 g  25.0 g 
Glucose   110.0 g  79.8 g 
Fructose -  40.2 g 
Xylitol   -  19.8 g 
Lipid 15.6  g  - 
 Na+   35 mEq  35 mEq 
 K +   27 mEq  22 mEq 
 M g2+   5 mEq  4 mEq 
 Ca2+   8.5 mEq  4 mEq 
 Cl
－   44 mEq  35 mEq 
 SO42－   5 mEq  4 mEq 
 Acetate
－   25 mEq  44 mEq 
 Gluconate
－ 8.5  mEq  4 mEq 
 Citrate3－ -   10 mEq 
 P    150  mg   154 mg 
 Zn    10  μmol  8 μmol 
NaHSO3 17  mg  412 mg 
pH 6.0  5.5 
     
Osmotic pressure ratio to physiological saline  Approx. 4  Approx. 5 
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DISCUSSION 
To reduce or prevent catheter-related blood 
stream infection (CRBSI), we have to understand the 
growth properties of the microorganisms that cause 
this condition. We have previously investigated the 
growth of the microorganisms that are known as the 
major causes of CRBSI (Staphylococcus aureus, Serratia 
marcescen, Bacillus cereus and Candida albicans) in total 
parenteral nutrition (TPN) solutions without lipid.10 
Therefore, we investigated the growth of the same 
microorganisms in TPN solutions containing lipid in 
the present study. 
In a commercial TPN solution containing lipid 
(ML), both standard strains and clinical isolates of all 
microorganisms (S. aureus, S. marcescens, B. cereus and 
C. albicans) increased rapidly at the original pH of 6.0, 
even without multivitamins. Although only C. albicans 
increased equally at any pH value, the growth of S. 
aureus, S. marcescens and B. cereus was suppressed as 
the pH value was reduced, with growth halted at 
pH4.9 (Experiment 1). However, these 3 bacterial 
species did not increase in another TPN solution con-
taining lipid (L+AT1V) even at pH5.5 and pH5.9 
(Experiment 3), which is the same result as obtained 
in the solution without lipid (AT1V or S+AT1V); this 
finding conflicts with the results of Experiment 1. The 
conflicting results from these 2 TPN solutions may be 
attributable to the difference in the bisulfite concen-
trations (ML contains NaHSO3 at a very low concen-
tration [20 ppm], but L+AT1V contains NaHSO3 at a 
relatively high concentration [400 ppm]) because the 
bactericidal effect of bisulfite is enhanced in acidic 
conditions.21 Therefore, the additional experiment 
(Experiment 4) was performed to investigate the effect 
of bisulfite concentration in the TPN solution con-
taining both lipid and multivitamins (MLV). As a re-
sult, the growth of the 3 bacterial species was sup-
pressed or halted at the same pH (5.4 or 5.7) as the 
concentration of NaHSO3 increased (20 ppm, 100 
ppm, and 200 ppm). These results suggest that the 
concentration of bisulfite in TPN solutions is an im-
portant factor for suppressing bacterial growth, espe-
cially between pH5.0 and pH6.0: the bacterial species 
cannot increase at pH5.9 with 400 ppm of NaHSO3, at 
pH5.7 or pH5.4 with 200 ppm of NaHSO3, and at 
pH5.0 with 20 ppm of NaHSO3. 
Other findings in the present study are as fol-
lows: 1) even if lipid is contained, the acidity of TPN 
solution is the critical factor suppressing the bacterial 
growth; 2) the addition of lipid enhances mildly the 
growth of the bacterial species in TPN solutions but 
does not affect the growth substantially; 3) the addi-
tion of multivitamins further enhances the growth of 
S. aureus but does not affect the growth of S. marces-
cens, B. cereus, and C. albicans in TPN solutions con-
taining lipid; 4) C. albicans can grow regardless of 
acidity, bisulfite, and lipid. 
Because C. albicans could grow at pH5.5 with 400 
ppm of NaHSO3 (AT1V) in our previous study,10 the 
effect of bisulfite concentration on the growth of C. 
albicans was not investigated in the present study. 
However, it has been reported that C. albicans could 
not increase in a TPN solution at pH4.4 with 500 ppm 
of NaHSO3, whereas C. albicans increased in the same 
TPN solution at pH4.4 with 40 ppm of NaHSO3 or at 
pH5.0 with 500 ppm of NaHSO3.23 Practically, Candida 
species can grow rapidly in almost all TPN solutions. 
The pH values of most of the recent TPN solu-
tions are within 5.0 and 6.0, similar to the old TPN 
solutions. On the other hand, the old TPN solutions 
contain bisulfite at relatively high concentrations, but 
the recent TPN solutions contain very low concentra-
tions of bisulfite or are bisulfite-free. To investigate 
bacterial growth in the recent TPN solutions, referring 
to results from the studies that used the old TPN so-
lutions that contained high concentration of bisulfite 
is not appropriate, even at the same pH range. In the 
recent TPN solutions containing lipid, some bacterial 
species may proliferate unless the pH value is 5.0 or 
less. Although the TPN solutions containing lipid can 
be theoretically improved to be bacteriostatic by re-
ducing the pH value and/or increasing the bisulfite 
concentration, more studies seem needed to improve 
the solution because lipid emulsions become unstable 
as the pH value reduces or as the concentration of 
bisulfite increases.  
In conclusion, Candida species can grow rapidly 
in almost all TPN solutions regardless of the acidity 
and the presence of lipid; also, some bacterial species 
may grow in TPN solutions containing lipid unless 
the pH value is 5.0 or less. Therefore, each TPN solu-
tion should be investigated to determine whether or 
not the bacterial species can proliferate.  
 ACKNOWLEDGEMENTS 
We are very grateful to Dr. Yoshifumi Inoue, 
Kawasaki Hospital, Kobe, Japan, for his helpful sug-
gestions. 
Conflict of Interest 
We declare that there are no conflicts of interest 
for all of us. 
References 
1.   Banton J. Techniques to prevent central venous catheter infec-
tion: products, research, and recommendations. Nutr Clin 
Pract. 2006;21:56-61. Int. J. Med. Sci. 2010, 7 
 
http://www.medsci.org 
109
2.    Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the 
management of intravascular catheter-related infection. Clin 
Infect Dis. 2001;32:1249-1272. 
3.   Llop J, Badia MB, Comas D, Tubau M, Jodar R. Colonization 
and bacteremia risk factors in parenteral nutrition catheteriza-
tion. Clin Nutr. 2001;20:527-534. 
4.   Allwood MC. Microbiological risks in parenteral nutrition 
compounding. Nutrition. 1997;13:60-61 
5.   Didier ME, Fischer S, Maki DG. Total nutrient admixtures ap-
pear safer than lipid emulsion alone as regards microbial con-
tamination: growth properties of microbial pathogens at room 
temperature. J Parenter Enteral Nutr. 1998;22:291-296.  
6.   Rowe CE, Fukuyama TT, Martinoff JT. Growth of microorgan-
isms in total nutrient admixtures. Drug Intell Clin Pharm. 
1987;21:633-638.  
7.   Gilbert M, Gallagher SC, Eads M, Elmore MF. Microbial growth 
patterns in a total parenteral nutrition formulation containing 
lipid emulsion. J Parenter Enteral Nutr. 1986;10:494-497. 
8.   Melly MA, Meng HC, Schaffner W. Microbial growth in lipid 
emulsions used in parenteral nutrition. Arch Surg. 
1975;110:1479-1481. 
9.   Goldmann DA, Martin WT, Worthington JW. Growth of bacte-
ria and fungi in total parenteral nutrition solutions. Am J Surg. 
1973;126:314-318. 
10.  Kuwahara T, Kaneda S, Shimono K, Inoue Y. Growth of mi-
croorganisms in total parenteral nutrition solutions without li-
pid. Int J Med Sci. 2010; 7: 43-47. 
11.  Crocker KS, Noga R, Filibeck DJ, Krey NH, Markovic M, Steffee 
WP. Microbial growth comparisons of five commercial paren-
teral lipid emulsions. J Parenter Enteral Nutr. 1984;8:391-395. 
12.    Jarvis WR, Highsmith AK. Bacterial growth and endotoxin 
production in lipid emulsion. J Clin Microbiol. 1984;19:17-20. 
13.  Keammerer D, Mayhall CG, Hall GO, Pesko LJ, Thomas RB. 
Microbial growth patterns in intravenous fat emulsions. Am J 
Hosp Pharm. 1983;40:1650-1653. 
14.  Kim CH, Lewis DE, Kumar A. Bacterial and fungal growth in 
intravenous fat emulsions. Am J Hosp Pharm. 
1983;40:2159-2161. 
15.  Deitel M, Fuksa M, Kaminsky VM, Vasic V. Growth of micro-
organisms in soybean oil emulsion and clinical implications. Int 
Surg. 1979;64:27-32. 
16.  Jarvis WR, Highsmith AK, Allen JR, Haley RW. Polymicrobial 
bacteremia associated with lipid emulsion in a neonatal inten-
sive care unit. Pediatr Infect Dis. 1983;2:203-209. 
17.  McKee KT, Melly MA, Greene HL, Schaffner W. Gram-negative 
bacillary sepsis associated with use of lipid emulsion in paren-
teral nutrition. Am J Dis Child. 1979;133:649-650. 
18.    Mershon J, Nogami W, Williams JM, Yoder C, Eitzen HE, 
Lemons JA. Bacterial/fungal growth in a combined parenteral 
nutrition solution. J Parenter Enteral Nutr. 1986;10:498-502.  
19.  O’Grady NP, Alexander M, Dellinger EP, et al. Guidelines for 
the prevention of intravascular catheter-related infections. 
MMWR. 2002;51:1-34. 
20.  Matsumoto S, Suenaga H, Naito K, Sawazaki M, Hiramatsu T, 
Agata N. Management of suspected nosocomial infection: an 
audit of 19 hospitalized patients with septicemia caused by Ba-
cillus species. Jpn J Infect Dis. 2000;53:196-202. 
21.  Murano A, Morinaga N, Iwamaru Y, et al. Acidic conditions 
enhance bactericidal effects of sodium bisulfite on Helicobacter 
pylori. Helicobacter. 2005;10:132-135. 
22.  Obayashi A, Oie S, Kamiya A. Microbial viability in prepara-
tions packaged for single use. Biol Pharm Bull. 2003;26:667-670. 
23.  Ishida K, Nakao S, Sata T, et al. Fungistatic action of the total 
parenteral nutrition (TPN) fluids against clinically isolated 
Candida albicans. Jpn J Pharm Health Care Sci. 2002;28:259-262. 